Sukumar Nagendran
Overview
Sukumar Nagendran received an average of $1M in total compensation, including $294K in salary, at Taysha Gene Therapies between 2022 and 2023. Sukumar Nagendran also received an average of $2M at AveXis between 2015 and 2016.
Source: SEC filings on April 18, 2024, May 8, 2023, and April 19, 2017.
Related executives
We found six more executives who work or worked at Taysha Gene Therapies and AveXis.
Sean Nolan
Taysha Gene Therapies
Chief Executive Officer
Kamran Alam
Taysha Gene Therapies
Chief Financial Officer
RA Session
Taysha Gene Therapies
Chief Executive Officer
Suyash FFPM
Taysha Gene Therapies
Chief Medical Officer
Sean Nolan
AveXis
Chief Executive Officer
Thomas Dee
AveXis